MRS2298? is a potent acyclic P2Y1 receptor antagonist with a K i of 29.6 nM. MRS2298 inhibits the ADP-induced aggregation of human platelets with an IC 50 of 62.8 nM. MRS2298 inhibits Ca 2+ rise in platelets with an IC 50 of 810 nM.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > P2Y Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.